Gilberto Filaci Selected Research

Gilberto Filaci Research Topics

Disease

17	Neoplasms (Cancer) 03/2023 - 01/2003
6	COVID-19 10/2022 - 01/2021
5	Inflammation (Inflammations) 12/2023 - 05/2009
5	Melanoma (Melanoma, Malignant) 03/2023 - 05/2013
4	Autoimmune Diseases (Autoimmune Disease) 12/2012 - 09/2007
4	Allergic Rhinitis 02/2010 - 09/2008
3	Bipolar Disorder (Manic Depressive Psychosis) 12/2023 - 10/2022
3	Neoplasm Metastasis (Metastasis) 03/2023 - 10/2007
3	Infections 12/2022 - 01/2021
3	Systemic Scleroderma (Systemic Sclerosis) 08/2016 - 05/2012
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2008 - 06/2002
2	Uveal melanoma 01/2023 - 04/2021
2	Ovarian Neoplasms (Ovarian Cancer) 08/2022 - 02/2020
2	Disease Progression 01/2022 - 05/2009
1	Severe Acute Respiratory Syndrome 01/2023
1	Vaccinia 12/2022
1	Breakthrough Infections 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	Ulcer 01/2022
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2022
1	Diabetic Foot 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 12/2021
1	Mesothelioma 08/2021
1	Stroke (Strokes) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Human Influenza (Influenza) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Ovarian Epithelial Carcinoma 02/2020
1	Ascites 02/2020
1	Viremia 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018

Drug/Important Bio-Agent (IBA)

11	AntigensIBA 01/2023 - 02/2006
10	CytokinesIBA 12/2023 - 06/2002
5	VaccinesIBA 12/2022 - 05/2009
5	Peptides (Polypeptides)IBA 01/2017 - 02/2006
4	Proteins (Proteins, Gene)FDA Link 10/2022 - 02/2020
4	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2021 - 02/2006
4	DNA (Deoxyribonucleic Acid)IBA 06/2009 - 01/2003
3	Immune Checkpoint InhibitorsIBA 03/2023 - 01/2021
2	CTLA-4 AntigenIBA 03/2023 - 01/2021
2	Blocking AntibodiesIBA 03/2023 - 04/2021
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 12/2013
2	Monoclonal AntibodiesIBA 01/2022 - 05/2013
2	Cancer VaccinesIBA 12/2021 - 12/2013
2	Interleukin-27 (Interleukin 27)IBA 08/2021 - 02/2020
2	Interleukin-6 (Interleukin 6)IBA 08/2021 - 12/2012
2	AntibodiesIBA 01/2021 - 05/2014
2	AllergensIBA 02/2010 - 12/2008
2	Interleukin-17 (Interleukin 17)IBA 02/2010 - 09/2008
2	LeptinIBA 01/2009 - 01/2009
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2007 - 01/2003
2	HLA Antigens (Human Leukocyte Antigens)IBA 02/2006 - 01/2003
1	guadecitabineIBA 03/2023
1	trametinibIBA 01/2023
1	cerivastatin (Kazak)FDA Link 01/2023
1	Fibroins (Fibroin)IBA 01/2023
1	EndocannabinoidsIBA 12/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 12/2022
1	Oxygen (Dioxygen)IBA 10/2022
1	lactate dehydrogenase C4IBA 10/2022
1	beta-Endorphin (Endorphin, beta)IBA 10/2022
1	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2022
1	Opioid Analgesics (Opioids)IBA 10/2022
1	ADAM17 ProteinIBA 08/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2022
1	Cisplatin (Platino)FDA LinkGeneric 08/2022
1	DisintegrinsIBA 08/2022
1	Bevacizumab (Avastin)FDA Link 08/2022
1	Carboplatin (JM8)FDA LinkGeneric 08/2022
1	Metalloproteases (Metalloproteinases)IBA 08/2022
1	remdesivirIBA 01/2022
1	sotrovimabIBA 01/2022
1	nirmatrelvir and ritonavir drug combinationIBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	EpitopesIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Docetaxel (Taxotere)FDA Link 12/2021
1	AsbestosIBA 08/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	LigandsIBA 01/2021
1	Adenosine DeaminaseIBA 01/2021
1	AmphiregulinIBA 01/2021
1	Viral RNAIBA 01/2021
1	LuciferasesIBA 06/2020
1	Carrier Proteins (Binding Protein)IBA 02/2020
1	Tyrosine (L-Tyrosine)FDA Link 02/2020
1	Melanoma-Specific AntigensIBA 09/2016
1	Cilostazol (Pletal)FDA LinkGeneric 08/2016

Therapy/Procedure

7	Therapeutics 01/2023 - 01/2008
6	Immunotherapy 04/2021 - 02/2006
1	Renal Dialysis (Hemodialysis) 10/2022
1	Salvage Therapy 01/2022
1	Artificial Skin 01/2022
1	Castration 12/2021
1	Drug Therapy (Chemotherapy) 12/2021
1	Art Therapy 01/2018